NCT00679250View on ClinicalTrials.gov

To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Allergic Rhinitis
Interventions
DRUG

levocetirizine

5 mg once nightly before visit

DRUG

placebo to levocetirizine

1 tablet once nightly before visit

Trial Locations (2)

DD1 9SY

Ninewells Hospital and Medical School (Tayside NHS Trust, University of Dundee), Dundee

PH1 1NX

Perth Royal Infirmary, Perth

All Listed Sponsors
lead

Brian J Lipworth

OTHER

NCT00679250 - To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis | Biotech Hunter | Biotech Hunter